Viviana Stephanie Costa Gagosian

Viviana Stephanie Costa Gagosian

Auto-generated profile, based on publicly available information

Viviana Stephanie Costa Gagosian

Graduate Program in Bioscience and Biotechnology, Carlos Chagas Institute (ICC/FIOCRUZ-PR), Curitiba 81310-020, PR, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2021 in Ecotoxicology
Verified
Journal Article
Closed access
PDF file
DSde Souza
de Souza
ACAndrezza Canavez
Andrezza Canavez
DSDesiree Cigaran Schuck
Desiree Cigaran Schuck
VGViviana Stephanie Costa Gagosian
Viviana Stephanie Costa Gagosian
IRIsisdoris Rodrigues
Isisdoris Rodrigues
DLDaniela Morais Leme
Daniela Morais Leme

17 October 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VGViviana Stephanie Costa Gagosian
Viviana Stephanie Costa Gagosian
RCRaquel Coronel
Raquel Coronel
BBBruna Caroline Buss
Bruna Caroline Buss
MSMaria Luiza Ferreira dos Santos
Maria Luiza Ferreira dos Santos
ILIsabel Liste
Isabel Liste
LFLeonardo Foti
Leonardo Foti
Research on in vitro skin models has advanced remarkably, driven by a better understanding of the skin and the search for more ethical and efficient methods. The development of these models was initially motivated by the need for reduced animal testing and a faster and more ethical approach for the safety evaluation of cosmetic and pharmaceutical products. Stricter regulations and growing ethical awareness have driven further evolution, resulting in more refined and reliable methods. Diversity of cell types is crucial to replicating the complexity of human skin, including epithelial, dendritic, endothelial, and adipose cells, providing environments that closely mimic the physiological skin environment. This allows for more precise studies on skin interactions with cosmetic, dermatological, and pharmaceutical products. In vitro skin models have applications in toxicity testing, dermatological product evaluation, skin ageing studies, and drug research, reducing dependence on animal testing. This review presents a look at the different types of in vitro skin models developed for various applications, with a brief look at their strengths and drawbacks. Models developed for disease-specific applications are also covered. Techniques such as bioprinting and organ-on-a-chip have revolutionised the manufacturing of these models. Challenges persist, such as the need to improve vascularisation and faithfully replicate skin architecture. The promising future of these models points to an exciting path forward for dermatological research and the cosmetic industry. This review addresses the history and regulations of skin models, explores various skin models, and highlights the most recent advances, outlining future perspectives and offering a comprehensive overview.

1 August 2017 in Homeopathy
Verified
Journal Article
Closed access
Jenifer Pendiuk GonçalvesJenifer Pendiuk Gonçalves
Jenifer Pendiuk Gonçalves
MSMaria Luiza Ferreira dos Santos
Maria Luiza Ferreira dos Santos
GRGustavo Rodrigues Rossi
Gustavo Rodrigues Rossi
VGViviana Stephanie Costa Gagosian
Viviana Stephanie Costa Gagosian
COCarolina Camargo de Oliveira
Carolina Camargo de Oliveira
Introduction: Zinc is an essential trace element necessary for life. Traditional and complementary medicines use zinc-based formulations to treat different classes of diseases. Basic research on homeopathic preparations of zinc are rare and there are a few published clinical cases describing its effects on patients. The use of cell-based models in drug screening is a reliable source of evidence.Methods: We sought to investigate experimental end-points using cell-based models to determine the effects of dilutions of Zincum metallicum prepared according to the Brazilian Homeopathic Pharmacopoeia. Murine RAW 264.7 macrophages and melanoma B16-F10 cell lines were cultured according to standard procedures. Cells were treated with either 5c, 6c or 30c Zincum metallicum and control cells with its respective vehicle (5c, 6c, or 30c Lactose). Macrophage activation by CD54 immunolabeling and intracellular reactive oxygen species (ROS) using DCFH-DA (2,7-dichlorodihydrofluorescein diacetate) were detected by flow cytometry. Phagocytic capacity (endocytic index) was quantified by light microscopy. Features of melanoma cells were analyzed by colorimetric assays to determine melanin content and cell proliferation rate. All obtained data were submitted to normality test followed by statistical analysis.Results: Zincum metallicum 6c shifted high ROS-producing macrophages to a low ROS-producing phenotype. Macrophage CD54 expression was increased by Zincum metallicum 5c. No changes in endocytic index were observed. Melanoma cells were not affected by any treatment we tested.Conclusions: Differing responses and non-linearity were found on macrophages challenged with Zincum metallicum at high dilutions. No changes in melanoma cells were observed. Customised assays using target cells can be useful to investigate high-dilution effects. Other cell types and conditions should be explored.

1 August 2022 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
ETEmanoela Lundgren Thá
Emanoela Lundgren Thá
VGViviana Stephanie Costa Gagosian
Viviana Stephanie Costa Gagosian
ACAndrezza Canavez
Andrezza Canavez
DSDesiree Cigaran Schuck
Desiree Cigaran Schuck
CBCarla Abdo Brohem
Carla Abdo Brohem
DLDaniela Morais Leme
Daniela Morais Leme

22 July 2019 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
Jenifer Pendiuk GonçalvesJenifer Pendiuk Gonçalves
Jenifer Pendiuk Gonçalves
FPFrancine Bittencourt Potrich
Francine Bittencourt Potrich
MSMaria Luiza Ferreira Dos Santos
Maria Luiza Ferreira Dos Santos
VGViviana Stephanie Costa Gagosian
Viviana Stephanie Costa Gagosian
GRGustavo Rodrigues Rossi
Gustavo Rodrigues Rossi
COCarolina Camargo de Oliveira
Carolina Camargo de Oliveira
Metastasis is responsible for the majority of deaths among patients with malignant melanoma. Despite recent advances, the majority of current and modern therapies are ineffective and/or financially unfeasible. Thus, in this study, we investigated two low‑cost highly‑diluted natural complexes (HDNCs) that have been shown to be effective against malignant melanoma in a murine model in vivo. The aim of this study was to determine the mechanisms through which these HDNCs directly affect melanoma cells, either alone or in an artificial tumor microenvironment, suppressing the metastatic phenotype, thus explaining previous in vivo effects. For this purpose, HDNC in vitro treatments of B16‑F10 melanoma cells, alone or in co‑culture with Balb/3T3 fibroblasts, were carried out. Molecular biology techniques and standard functional assays were used to assess the changes in molecule expression and in cell behaviors related to the metastatic phenotype. Melanoma progression features were found to be regulated by HDNCs. Molecules related to cell adhesion (N‑cadherin, β1‑integrin and CD44), and migration, extracellular matrix remodeling and angiogenesis were modulated. The cell migratory, invasive and clonogenic capacities were reduced by the HDNCs. No loss of cell proliferation or viability were observed. On the whole, the findings of this study indicate that HDNCs directly reprogram, molecularly and functionally, melanoma cells in vitro, modulating their metastatic phenotype. Such findings are likely to be responsible for the attenuation of tumor growth and lung colonization previously observed in vivo.